SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

Share Price is delayed by 15 minutes
Get Live Data
1,147.00    10.50 (0.92%)
Bid:
1,144.00
Ask:
1,145.00
Spread: 1.00 (0.087%)
Market Cap: £6.89b
PSON Live PriceLast checked at - London Stock Exchange

Intraday Pearson Share Chart

Contract

19 Apr 2022 07:00

RNS Number : 5041I
Pearson PLC
19 April 2022
 

19 April 2022

 

Pearson plc

("Pearson")

 

Pearson's OPM contract with ASU to end in 2023 - no change to Group guidance

LONDON, 19 APRIL 2022: Pearson, the world's leading learning company, today announces that its Online Program Management (OPM) partnership with Arizona State University (ASU) will end in June 2023 and reiterates existing Group financial guidance.

 

Over the last 10 years, the ground-breaking collaboration between Pearson and ASU has helped the university enhance and expand its online learning services and resources. Together, ASU and Pearson share a deep commitment to making an impact on the lives of learners and this highly successful partnership has helped tens of thousands of students to reach their potential by obtaining a college degree. 

 

The profit impact of the contract termination will be modest in 2022 and 2023 and will be offset thereafter through eliminating related costs and re-directing investment across our strategic growth opportunities. There is no change to the Group financial guidance for 2022 that we laid out at our preliminary results in February this year and our medium-term Group level guidance is also unchanged. We continue to expect to achieve mid-single digit Group revenue CAGR from 2022 to 2025 and for Group margins to remain relatively stable in the near term, as we invest to drive growth, improving by 2025 to mid-teens.

 

This announcement contains inside information.

 

---ENDS---

 

Contacts

 

Investor Relations

Jo Russell

James Caddy

+44 (0) 7785 451 266

+44 (0) 7825 948 218

 

Media

Tom Steiner

Gemma Terry

+44 (0) 7787 415 891

+44 (0) 7841 363 216

 

Teneo

Charles Armitstead

+44 (0) 7703 330 269

 

 

Forward looking statements

Except for the historical information contained herein, the matters discussed in this statement include forward-looking statements. In particular, all statements that express forecasts, expectations and projections with respect to future matters, including trends in results of operations, margins, growth rates, overall market trends, the impact of interest or exchange rates, the availability of financing, anticipated costs savings and synergies and the execution of Pearson's strategy, are forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that will occur in future. They are based on numerous assumptions regarding Pearson's present and future business strategies and the environment in which it will operate in the future.

 

There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including a number of factors outside Pearson's control. These include international, national and local conditions, as well as competition. They also include other risks detailed from time to time in Pearson's publicly-filed documents and you are advised to read, in particular, the risk factors set out in Pearson's latest annual report and accounts, which can be found on its website (plc.pearson.com). Any forward-looking statements speak only as of the date they are made, and Pearson gives no undertaking to update forward-looking statements to reflect any changes in its expectations with regard thereto or any changes to events, conditions or circumstances on which any such statement is based. Readers are cautioned not to place undue reliance on such forward-looking statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTEAELPFSXAEAA
Date   Source Headline
3rd Apr 20255:24 pmRNSTransaction in Own Shares
2nd Apr 20255:28 pmRNSTransaction in Own Shares
1st Apr 20255:19 pmRNSTransaction in Own Shares
1st Apr 202510:00 amRNSTotal Voting Rights
1st Apr 20259:30 amRNSDirector/PDMR Shareholding
31st Mar 20255:21 pmRNSTransaction in Own Shares
28th Mar 20255:21 pmRNSTransaction in Own Shares
28th Mar 20251:31 pmRNSHolding(s) in Company
27th Mar 20255:16 pmRNSTransaction in Own Shares
27th Mar 202510:00 amRNSNotice of AGM
26th Mar 20255:27 pmRNSTransaction in Own Shares
25th Mar 20255:41 pmRNSTransaction in Own Shares
24th Mar 20255:18 pmRNSTransaction in Own Shares
21st Mar 20256:00 pmRNSTransaction in Own Shares
20th Mar 20255:52 pmRNSTransaction in Own Shares
19th Mar 20256:06 pmRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSAnnouncement of share repurchase programme
14th Mar 202511:56 amRNSAnnual Financial Report
14th Mar 202510:06 amRNSDirector Declaration
7th Mar 202512:00 pmRNSDirectorate Change
5th Mar 202510:08 amRNSHolding(s) in Company
3rd Mar 202510:30 amRNSTotal Voting Rights
28th Feb 20257:00 amRNSPearson 2024 Preliminary Results
3rd Feb 202511:13 amRNSDirector/PDMR Shareholding
3rd Feb 202510:45 amRNSTotal Voting Rights
24th Jan 202512:17 pmRNSDirector/PDMR Shareholding
16th Jan 20257:00 amRNSPearson 2024 Trading Statement
6th Jan 20254:07 pmRNSDirector/PDMR Shareholding
2nd Jan 202510:25 amRNSTotal Voting Rights
16th Dec 20243:50 pmRNSDirector/PDMR Shareholding
2nd Dec 20244:18 pmRNSTotal Voting Rights
2nd Dec 20244:00 pmRNSBlock listing Interim Review
1st Nov 202410:00 amRNSTotal Voting Rights
30th Oct 20241:39 pmRNSResult of AGM - Update Statement
29th Oct 20247:00 amRNSPearson 2024 Nine Month Trading Update
1st Oct 20243:50 pmRNSDirector/PDMR Shareholding
1st Oct 202411:45 amRNSTotal Voting Rights
18th Sep 20243:54 pmRNSDirector/PDMR Shareholding
5th Sep 20244:40 pmRNSBond Issue
4th Sep 20241:05 pmRNSDirector/PDMR Shareholding
2nd Sep 202412:45 pmRNSTotal Voting Rights
21st Aug 202410:42 amRNSHolding(s) in Company
9th Aug 20247:00 amRNSTransaction in Own Shares
8th Aug 20244:02 pmRNSDirector Declaration
8th Aug 20244:00 pmRNSDirector/PDMR Shareholding
8th Aug 20247:00 amRNSTransaction in Own Shares
7th Aug 20247:00 amRNSTransaction in Own Shares
6th Aug 20247:00 amRNSTransaction in Own Shares
5th Aug 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.